Geneos Wealth Management’s Anavex Life Sciences AVXL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$149K	Buy	48,600 +400	+0.8%	+$1.73K	﹤0.01%	1053
2025 Q4	$172K	Buy	48,200 +5,800	+14%	+$35.5K	﹤0.01%	969
2025 Q3	$377K	Sell	42,400 -2,650	-6%	-$26.9K	0.01%	728
2025 Q2	$415K	Sell	45,050 -45,250	-50%	-$386K	0.01%	767
2025 Q1	$775K	Buy	90,300 +36,525	+68%	+$345K	0.01%	752
2024 Q4	$578K	Sell	53,775 -14,450	-21%	-$111K	0.02%	549
2024 Q3	$388K	Sell	68,225 -21,500	-24%	-$124K	0.01%	614
2024 Q2	$379K	Buy	89,725 +15,325	+21%	+$62K	0.02%	561
2024 Q1	$379K	Buy	74,400 +6,800	+10%	+$38.3K	0.02%	555
2023 Q4	$629K	Buy	67,600 +25,500	+61%	+$176K	0.03%	419
2023 Q3	$276K	Hold	42,100	–	–	0.01%	598
2023 Q2	$342K	Hold	42,100	–	–	0.02%	552
2023 Q1	$361K	Buy	42,100 +2,000	+5%	+$20K	0.02%	508
2022 Q4	$371K	Buy	40,100 +6,600	+20%	+$70.5K	0.02%	478
2022 Q3	$345K	Sell	33,500 -5,300	-14%	-$55.9K	0.02%	467
2022 Q2	$399K	Buy	38,800 +7,150	+23%	+$67.7K	0.02%	558
2022 Q1	$389K	Buy	31,650 +9,200	+41%	+$113K	0.02%	607
2021 Q4	$389K	Hold	22,450	–	–	0.01%	658
2021 Q3	$402K	Buy	22,450 +950	+4%	+$18.9K	0.02%	631
2021 Q2	$528K	Sell	21,500 -4,000	-16%	-$59.2K	0.02%	549
2021 Q1	$308K	Buy	25,500 +1,000	+4%	+$10.9K	0.01%	785
2020 Q4	$366K	Buy	24,500 +500	+2%	+$2.63K	0.01%	629
2020 Q3	$92K	Buy	24,000 +10,000	+71%	+$43K	﹤0.01%	976
2020 Q2	$71K	Hold	14,000	–	–	﹤0.01%	1064
2020 Q1	$40K	Hold	14,000	–	–	﹤0.01%	1206
2019 Q4	$35K	Hold	14,000	–	–	﹤0.01%	1430
2019 Q3	$46K	Hold	14,000	–	–	﹤0.01%	1219
2019 Q2	$47K	Hold	14,000	–	–	﹤0.01%	1218
2019 Q1	$42K	Hold	14,000	–	–	﹤0.01%	1224
2018 Q4	$21K	Hold	14,000	–	–	﹤0.01%	1473
2018 Q3	$38K	Buy	+14,000	New	+$39.5K	﹤0.01%	1293